or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 17.14 1.96% 0.33
    DNLI closed up 1.96 percent on Friday, May 3, 2024, on 71 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    Earnings due: May 6
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    Doji - Bearish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    MACD Bullish Signal Line Cross Bullish 1.96%
    Wide Bands Range Expansion 1.96%
    Gapped Up Strength 1.96%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 11 hours ago
    Up 5% about 12 hours ago
    Up 1 ATR about 12 hours ago
    Rose Above 20 DMA about 12 hours ago
    Rose Above Previous Day's High about 12 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 1 Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
    Apr 29 Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
    Apr 9 Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
    Mar 29 Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
    Mar 28 Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
    Mar 22 Denali Therapeutics files to sell 29.29M shares of common stock for holders
    Mar 19 Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%
    Mar 7 Denali: Leveraging Transport Vehicle Technology For Neurological Gains
    Feb 28 Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
    Feb 27 Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.31
    52 Week Low 14.56
    Average Volume 1,230,746
    200-Day Moving Average 20.37
    50-Day Moving Average 18.88
    20-Day Moving Average 16.91
    10-Day Moving Average 15.92
    Average True Range 0.89
    RSI (14) 48.72
    ADX 22.05
    +DI 31.51
    -DI 27.10
    Chandelier Exit (Long, 3 ATRs) 17.09
    Chandelier Exit (Short, 3 ATRs) 17.22
    Upper Bollinger Bands 19.59
    Lower Bollinger Band 14.23
    Percent B (%b) 0.54
    BandWidth 31.71
    MACD Line -0.79
    MACD Signal Line -0.92
    MACD Histogram 0.1356
    Fundamentals Value
    Market Cap 2.37 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -18.23
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.43
    Resistance 3 (R3) 18.54 18.22 18.22
    Resistance 2 (R2) 18.22 17.89 18.17 18.14
    Resistance 1 (R1) 17.68 17.69 17.52 17.57 18.07
    Pivot Point 17.36 17.36 17.28 17.31 17.36
    Support 1 (S1) 16.82 17.03 16.66 16.71 16.21
    Support 2 (S2) 16.50 16.83 16.45 16.14
    Support 3 (S3) 15.96 16.50 16.07
    Support 4 (S4) 15.85